Clinical Trials Directory

Trials / Unknown

UnknownNCT03216135

Microbiome Involvement With Barrett's Esophagus and Progression to Esophageal Adenocarcinoma

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Ochsner Health System · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will examine the hypothesis that altered esophageal microbiome leads to the development of esophageal adenocarcinoma (EAC). The aims of the project are, firstly the confirmation of relational data on the study cohort, using the methods developed and applied at the laboratory at University of Queensland Diamantina Institute (UQDI). Second, to generate a tissue microarray resource future tissue in-situ validation of microbes. And finally, to develop a biobank of clinical isolates of relevant esophageal microbes for future functional studies.

Detailed description

Gastroesophageal reflux disease, GERD, can lead to a change of the esophagus lining to a protective cell type, termed Barrett's esophagus (BE). A diagnosis of BE greatly increases the risk of developing esophageal adenocarcinoma (EAC). The incidence of EAC has been rapidly rising in the last 30 years, and the cancer has a high mortality rate. Understanding the involvement of the esophageal microbiota could lead to prevention strategies to this increasing health concern. This study will examine the hypothesis that altered esophageal microbiome leads to the development of esophageal adenocarcinoma (EAC). The aims of the project are, firstly the confirmation of relational data on the study cohort, using the methods developed and applied at the laboratory at University of Queensland Diamantina Institute (UQDI). Second, to generate a tissue microarray resource future tissue in-situ validation of microbes. And finally, to develop a biobank of clinical isolates of relevant esophageal microbes for future functional studies.

Conditions

Timeline

Start date
2017-07-20
Primary completion
2017-11-01
Completion
2017-12-01
First posted
2017-07-13
Last updated
2017-07-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03216135. Inclusion in this directory is not an endorsement.